Extract
Note: Please read the complete
full text with Figures and Tables at
Introduction
Recent advances in experimental investigations of glial
networks challenged the neuronal doctrine that, since
1894[1], dominated our perception of brain function. The new concept, which regards brain as a dynamically interconnected reticular
network of internally connected glial syncytium and synaptically connected neuronal circuits, is now
emerging[2,3]. This new concept also includes new and more complex pathways of intercellular signaling, which can be executed in two modes, the
wiring and the volume transmission[4_7]. The wiring transmission represents a fast local and unidirectional mode of
intercellular signaling executed through chemical and electrical synapses. The volume transmission is a slow and global route for
cellular communications, which takes either extracellular (diffusion of signaling molecules in the extracellular space) or
intracellular (diffusion of messengers and metabolites in the cellular syncytium connected by gap junctions) route. These
two modes of transmission operating in concert permit extreme sophistication in information processing within neural circuits.
Glial cells, which account for 60% of all cells in the nervous system of rodents and approximately 90% of all neural cells
in humans, perform a wide variety of vital
functions[8]: radial glial cells and "stem" astrocytes control neurogenesis, neural
cell development and migration; astroglia divide gray matter into neuronal-glial-vascular units and are actively involved in
synaptic transmission; oligodendrocytes provide for axonal myelination; and microglia act as a main defense system in the
nervous tissue. On a molecular level, integration within neuronal-glial networks very much relies on a specific signaling
system that uses Ca2+ ions as the universal cellular messengers (Figure
1)[9_11]. Indeed, the Ca2+ signaling system controls
integration in both synaptically connected neuronal synaptic networks (by controlling neurotransmitter release from
presynaptic terminals and secretion of neurohormones) and within glial syncytium (by providing the glia with the means of
long-range signaling by propagating calcium waves).
Glial cells are also heavily involved in many types of brain
diseases[12]. Insults to the nervous system trigger specific glial
reactions represented by reactive astrogliosis, Wallerian degeneration and activation of microglia. These glial responses are
of critical importance for the neural pathology. Conceptually, it is important to remember that astroglial cells can outlive
neurones. Moreover, astrocytes very often are activated in the presence of dying or already dead neurones, whereas
neurones cannot survive without astroglial support. Likewise, failure of oligodendrocytes leads to the development of
demyelinating diseases, which severely affect axonal function. Finally, failure of microglial defense leaves the central
nervous system (CNS) open to infection-induced damage.
In this essay I shall overview the main properties of physiological glial calcium signaling and give several examples of glial
calcium involvement in neuropathology.
Glial calcium signaling
Ca2+ signaling as a substrate for glial excitability
Although glial cells are non-excitable from the classical physiological
point of view (they are unable to generate regenerative action potentials), they are able to respond to external stimulation with
generation of intracellular Ca2+ signals. The latter result from activation of
Ca2+ fluxes either through plasmalemma or through
intracellular membrane, which form a specific organelle known as endoplasmic reticulum (ER). This intracellular membrane,
the endomembrane, acts as an excitable
media[13_16]. The excitability of the endomembrane is determined by a specific
complement of intracellular Ca2+ channels and endo(sarco)plasmic reticulum calcium ATP-ases (SERCA), which act as
Ca2+ pumps that transport
Ca2+ against the steep concentration gradient from the cytosol into the ER
lumen[17]. The intra-ER free
Ca2+ concentration (or intraluminal
Ca2+ concentration,
[Ca2+]L) reaches several hundreds of micromoles and creates an
electro-driving force aimed at the
cytosol[18_20]. Intracellular
Ca2+ channels residing in the endomembrane are represented by
several families: (1) ryanodine receptors (RyRs) directly controlled by cytosolic
Ca2+; (2) inositol-1,4,5-trisphosphate
receptors (InsP3Rs), sensitive to both cytosolic
Ca2+ and second messenger
InsP3; and (3) possibly NAADP
receptors[21_23]. Importantly, free
Ca2+ ions within the lumen of ER act as the main regulators of both
Ca2+ release channels and SERCA
Ca2+ pumps. Decrease in
[Ca2+]L activates SERCA uptake and inhibits
Ca2+ release channels, whereas elevation of
[Ca2+]L slows down the SERCA pumping and increases the sensitivity of
Ca2+ release channels to
stimulation[24,25]. Local
Ca2+ release from the ER, manifested in a form of "sparks" or
"puffs"[14], creates microdomains of an increased
Ca2+ concentration, which in turn are able to recruit neighbouring
Ca2+ release channels and thus produce a propagating wave of excitation of the endomembrane.
This "propagating" Ca2+ wave serves as a substrate for long-range signaling in glial syncytium; as glial
Ca2+ waves are able to cross the cell-to-cell boundaries and travel a long distance though astroglial
networks[26_29]. Mechanisms responsible for
the generation of propagating Ca2+ waves are complex and involve diffusion of
InsP3 through gap junctions, connecting
astroglial cells, and release and extracellular diffusion of transmitters such as ATP or glutamate (Ref 30_33 and Figure 2).
Glial Ca2+ and integration in neuronal-glial
networks The incoming signaling, activating glial cells are represented by
neurotransmitters, released during neuronal synaptic communications. Astrocytes form structures that closely enwrap
the majority of synapses in grey matter. As a consequence, the astroglial compartment can be regarded as an inseparable
part of the synapse (the concept of tripartite
synapse[34_36]). Astrocytes express all types of known neurotransmitters
receptors, and most importantly expression of these receptors shows remarkable regional heterogeneity, being tuned to
specifically sense neurotrans-mitters, released in the adjoining
synapses[3,29,36_41]. Many glial receptors belong to the metabotropic
variety, and their activation leads to formation of
InsP3 and subsequent Ca2+ release from the ER. In addition, astrocytes
also express ionotropic receptors, which can produce cell depolarization and also serve as a route for plasmalemmal
Ca2+ entry. Astrocytes of the brain grey matter usually express
gluta-mate and P2
purinoreceptors[41_44], which is not surprising
as glutamate and ATP are involved in excitatory neurotransmission in the majority of central synapses. Synaptic activity
triggers activation of glial receptors and generation of both ionotropic and cytosolic
Ca2+ responses in virtually all types of astrocytes studied in brain
in situ preparations[45_47]. Astroglial calcium signals in turn control regulated exocytosis of
"glio" transmitters, which include glutamate,
D-serine, ATP and perhaps other neuro-active
substances[48_53]. These "glio" transmitters directly affect neurones residing within astroglial territories and might either directly excite them, or
modulate the ongoing synaptic
transmission[54_58]. Calcium signals traveling within astrocytes also create a functional link
between neuronal activity and local circulation, by triggering a release of vasoactive substances from astrocyte endfeet,
which engulf brain capillaries[59,60].
To conclude, glial calcium signaling acts as a molecular mechanism for integration within glial syncytium and between
glial and neuronal circuits. Quite naturally, this powerful signaling system also plays an important role in neuropathology.
Glial calcium in neuropathology
Brain ischaemia Disruption or insufficiency of the blood flow in the CNS causes considerable damage to the nervous
tissue. The blood flow in the brain can be compromised either by blood vessel rupture, which leads to haemorrhage, or by a
restraint of blood supply to the whole brain or to its parts, which is generally known as brain ischemia. The latter can be
global (when brain blood supply stops because of, for example, heart failure) or focal (when regional blood flow is reduced or
ceased completely due to vascular occlusion). Focal brain ischemia is manifested by stroke. Both global and focal ischemia
trigger neural cell death, which primarily results from the limitation of oxygen supply (hypoxia or anoxia) as well as with
restrictions in delivery of metabolic substrates.
Focal ischemia produces spatially distinct damage areas. At the very centre of the ischemic zone lies the infarction core,
surrounded by ischemic penumbra. The core is formed almost instantly after the cessation of blood flow and is represented
by an area of pan-necrosis of all neural elements; formation of penumbra is much slower and might take several days.
All types of glial cells are affected by the ischemic insult and their reaction, to a very considerable extent, determines the
outcome of the stroke. Acute ischemia rapidly kills both neurones and oligodendrocytes, but astroglial cells are generally
more resistant. The swift death of neurones and oligodendrocytes is largely mediated through glutamate excitotoxi-city: the
cells located within the infarction core rapidly lose the ability to maintain transmembrane ion gradients and undergo anoxic
depolarization. This results in Ca2+ influx, which in turn triggers a massive release of glutamate. The latter activates
ionotropic receptors and further exacerbates cellular
Ca2+ overload. Persistent and severe elevation in
[Ca2+]i in turn compromises mitochondria, induces oxidative stress and activates numerous proteolytic enzymes. All of these processes result in
necrosis. In neurones, the primary route for
Ca2+ entry after exposure to glutamate is mediated by NMDA
receptors[61_63]. In oligodendrocytes and oligodendrocyte precursors,
Ca2+ enters through both
Ca2+-permeable AMPA/kainate
receptors[64] and through NMDA receptors, recently discovered in
oligodendroglia[65_67]. Oligodendroglial death during ischemic insults
is rapid and can cause severe demyelination syndromes, such as periven-tricular
leucomalacia[68] or Binswanger¡¯s
disease[69].
Astrocytes are considerably less sensitive to glutamate excitotoxicity. Moreover, astroglial cells which, by virtue of high
expression of glutamate transporters, are the main sink of glutamate in the brain (for example, up to 80% of glutamate released
during synaptic activity is accumulated by astro-cytes) form the chief defensive system against glutamate toxicity. In cell
culture conditions, astrocytes can survive for up to 12 h in conditions of oxygen and glucose
deprivation[70]. In contrast, in
vivo the gray matter astrocytes are more vulnerable to ischemia, and relatively prolonged occlusion of blood flow (approximately
2 h) causes prominent astroglial
death[71]. The astroglial responses to acute ischemia are mainly manifested by a rapid
increase in [Ca2+]i,
which starts to develop several minutes after induction of
ischemia[72,73]. This cytoplasmic
Ca2+ rise results from both plasmalemmal
Ca2+ entry and Ca2+ release from the ER calcium
stores. Interestingly, the magnitudes of ischemia-induced
[Ca2+]i elevation was much larger in
in situ (brain slice) preparations compared to isolated
cells[73].
Notwithstanding these rapid reactions, astroglial cells can survive for a long time in the penumbra, where they may, to a
considerable degree, determine the progression of the infarction and its outcome. First, astroglial cells can maintain
anaerobic glycolysis and thus supply adjacent neurones with an energy supply in a form of
lactate[74]. Second, astrocytes act as
powerful scavengers of reactive oxygen species, as they contain high concentrations of glutathione and ascorbate, which
represent principal anti-oxidants in the CNS. The ability of astrocytes to protect neurones against reactive oxygen species
has been clearly demonstrated in vitro: neuronal_astroglial cultures were much more resistant to
injury produced by superoxide or hydrogen peroxide,
compared to purified neuronal
cultures[75]. Third, astroglial networks
are instrumental for extracellular potassium
buffering[76], and by dispersing potassium from the affected areas astrocytes
protect neural tissue against severe depolarization. Finally, astroglial calcium signals might be instrumental in initiating
reactive gliosis, which can determine the neurological outcome in a post-ischemic period.
The role played by astrocytes in brain ischemia can, however, be detrimental, and in certain conditions astroglial reaction
can exacerbate the nerve tissue damage. In parti-cular, astrocytes might play a leading role in propagation of the cell damage
through penumbra and even in triggering death of neurones in areas distal to the ischemic core. In particular, propagating
Ca2+ waves, initiated by focal ischemia, can spread through astroglial syncytium and cause release of glutamate and some
other, still unidentified, pathological factors; these factors, in their turn, can cause neural cell death, thus leading to
expansion of the infarct[77_79]. In principle, astroglial networks seem to be the main players in propagation of damaging signals from
infarction core to the surrounding tissue, as indeed signaling through neuronal circuits can be excluded because neuronal
excitability is lost after even a mild reduction of cerebral blood flow. Of course, the extent and velocity of infarct expansion
will depend on many factors, affecting astroglial function (such as the degree of tissue acidification, and depth of metabolic
failure), yet the astroglial performance might very likely determine the progression of brain ischemia.
Spreading depression The spreading depression (initially described in 1944 by Aristide
Leào[80]) is a wave of severe neuronal
depolarization that spreads through the gray matter at a velocity of approximately 1.5_7.5 mm/min. This propagating wave of
depolarization can occur in normal brain tissue as a consequence of sharp local increase in extracellular
K+ concentration or release of glutamate, both of which can be triggered by excessive neuronal activity. This wave of spreading depression, for
example, can lead to migraine
attacks[81]. The spreading depression can also be initiated by mechanical or ischemic damage,
and as such it is often observed in the penumbra surrounding the infarction core. In the latter case, the waves of spreading
depression play an important role in the expansion of the infarct through the penumbra, so that every next wave increases the
damage[82,83]. In the normal, non-ischemic tissue spreading depression does not trigger cell damage, although it might initiate
activation of microglia[84] and mild reactive
astrogliosis[85].
The precise mechanisms of spreading depression are not fully understood; most likely its initiation results from several
factors acting in concert. Nonetheless, it can be linked to astroglial calcium waves with similar propagation velocity.
Interestingly, disruption of astroglial gap junctions inhibits both propagating
Ca2+ waves and the propagation of waves of
spreading depression[82].
Epilepsy Epilepsy is a severe and often debilitating neurological disorder, manifested by seizures, accompanied with
motor abnormalities and disturbances of consciousness and behavior. The cellular substrate of epilepsy is represented by
a spontaneous and synchronous depolarization of all neurones within the epileptic foci, known as a paroxysmal
depolarization shift (PDS). The PDS is generated by simultaneous activation of postsynaptic glutamate receptors and lasts for 50_200
ms. The actual nature of the synchronous release of glutamate remained elusive for many years, although in 1986 it was
suggested that it might have a non-synaptic
origin[86,87]. Experimental evidence gained very
recently[88_90] indicates that astroglial cells might act as a source of glutamate, which induces PDS and epileptiform neuronal activity.
The experimental PDS, induced by several interventions (superfusion of brain slices with low
Ca2+ solutions, addition of
K+ channel blocker 4-aminopyridine, or inhibition of
GABAA receptors by bicuculline) was developing in conditions of
synaptic isolation, that is, when neuronal firing was completely blocked by
tetrodotoxin[90]. This experiment suggested that
the glutamate, which triggers PDS, can be released from non-neuronal structures. Indeed, when
Ca2+ waves were induced in astrocytes (by selective liberation of UV-sensitive "caged"
Ca2+), this resulted in release of glutamate and initiation of PDS.
Two-photon confocal video-imaging of the cortical structures also demonstrated that, usually, astroglial
Ca2+ waves preceded PDS and neuronal discharges and moreover, intraperitoneal injection of anti-epileptic drugs reduced both astroglial
Ca2+ waves and neuronal
PDS[90]. Obviously, the experimental epileptic models cannot completely reproduce the disease
situation, although it is known that epilepsy is accompanied with massive reactive gliosis that develops even before any
neurodegenerative changes and appearance of fully developed
seizures[91,92]. It could be that reactive astrocytes have
altered Ca2+ signaling, which might further add to the pathogenesis of epileptic seizures. Introduction of astrocytes into the
epileptic circuit can explain the precise synchronization between many neurones. Every astrocyte in gray matter could be
connected with up to 100 000 synapses within its domain, therefore, glutamate released from the astroglial cell might reach all
the neurones virtually simultaneously.
Alzheimer¡¯s disease Alzheimer¡¯s disease (AD), initially described by Alois Alzheimer as a malignant dementia in a
51-year-old woman[93], is manifested by: (1) occurrence of
b-amyloid protein deposits in the form of plaques; (2) intraneuronal
accumulation of abnormal tau-protein filaments in the form of neuronal tangles; and (3) profound neuronal loss leading to
severe dementia. Histopathology of AD is also characterized by prominent reactive astrogliosis and activation of
microglia[94].
The effects of astroglia in the progression of AD can be both protective and detrimental. Astroglial cells act as the natural
scavenger of amyloid proteins. Reactive astrocytes can migrate towards deposits of
b-amyloid, then accumulate and degrade
them[95]. In contrast, astrocytes can mediate neuronal injury: overloading of astroglial cells with
b-amyloid triggers their degeneration. As a consequence, the astrocytes withdraw their processes from the neuronal membranes and synapses
residing within their territory, exacerbating neuronal
damage[94]. Astroglial calcium waves can provide a specific mechanism
for neurotoxicity in AD. Recently, it was shown that superfusion of neuronal-glial co-cultures with
b-amyloid triggers [Ca2+]i oscillations in astrocytes, without inducing neuronal
Ca2+ signals. These Ca2+ waves, maintained for long periods (as long
as b-amyloid was present in the culture media) induced degenerative changes and eventual death of neighboring neurones.
Inhibition of astroglial Ca2+ signals by culture treatment with thapsigargin was
neuroprotective[96,97].
Conclusions
Glial calcium signaling acts as a powerful system that provides for integration within glial syncytium and between glial
and neuronal circuits. These calcium signals arise in response to the stimulation of glial receptors by neurotransmitters and
neurohormones; they give birth to propagating
Ca2+ waves that spread though glial networks and control release of "glio"
transmitters, which signal to neuronal networks. In pathological conditions, calcium signaling is intimately involved in the
regulation of glial responses, which have both protective and detrimental effects on the nervous tissue.
References
References
1 Exner S. Entwurf zur physiologischen Erklärung der Psychischen Erscheinungen. Leipzig/Vienna: Deiticke; 1894.
2 Nedergaard M, Ransom B, Goldman SA. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci
2003; 26: 523_30.
3 Volterra A, Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 2005; 6:
626_40.
4 Bloom FE. Integration of wiring transmission and volume transmission. Prog Brain Res 2000; 125: 21_6.
5 Ridet I, Privat A. Volume transmission. Trends Neurosci 2000; 23: 58_9.
6 Sykova E, Chvatal A. Glial cells and volume transmission in the CNS. Neurochem Int 2000; 36: 397_409.
7 Dermietzel R. Gap junction wiring: a `new' principle in cell-to-cell communication in the nervous system? Brain Res Brain Res Rev 1998;
26: 176_83.
8 Kettenmann H, Ransom BR, editors. Neuroglia. Oxford: OUP; 2005.
9 Berridge MJ. Neuronal calcium signaling. Neuron 1998; 21: 13_26.
10 Petersen OH, Michalak M, Verkhratsky A. Calcium signalling: past, present and future. Cell Calcium 2005; 38: 161_9.
11 Verkhratsky A. Calcium ions and integration in neural circuits. Acta Physiol 2006 (in press).
12 Seifert G, Schilling K, Steinhauser C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat Rev Neurosci 2006;
7: 194_206.
13 Berridge MJ. The endoplasmic reticulum: a multifunctional signaling organelle. Cell Calcium 2002; 32: 235_49.
14 Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003; 4:
517_29.
15 Bootman MD, Petersen OH, Verkhratsky A. The endoplasmic reticulum is a focal point for co-ordination of cellular activity. Cell
Calcium 2002; 32: 231_4.
16 Verkhratsky A. Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. Physiol Rev 2005; 85:
201_79.
17 Vangheluwe P, Raeymaekers L, Dode L, Wuytack F. Modulating sarco(endo)plasmic reticulum
Ca2+ ATPase 2 (SERCA2) activity: cell biological implications. Cell Calcium 2005; 38:
291_302.
18 Solovyova N, Veselovsky N, Toescu EC, Verkhratsky A.
Ca2+ dynamics in the lumen of the endoplasmic reticulum in sensory neurons:
direct visualization of Ca2+-induced
Ca2+ release triggered by physiological
Ca2+ entry. EMBO J 2002; 21: 622_30.
19 Solovyova N, Verkhratsky A. Monitoring of free calcium in the neuronal endoplasmic reticulum: an overview of modern approaches. J
Neurosci Methods 2002; 122: 1_12.
20 Kiryushko DV, Savtchenko LP, Verkhratsky AN, Korogod SM. Theoretical estimation of the capacity of intracellular calcium
stores in the Bergmann glial cell. Pflugers Arch 2002; 443: 643_51.
21 Hamilton SL. Ryanodine receptors. Cell Calcium 2005; 38: 253_60.
22 Galione A, Ruas M. NAADP receptors. Cell Calcium 2005; 38: 273_80.
23 Bezprozvanny I. The inositol 1,4,5-trisphosphate receptors. Cell Calcium 2005; 38:
261_72.
24 Burdakov D, Verkhratsky A. Biophysical re-equilibration of
Ca2+ fluxes as a simple biologically plausible explanation for complex
intracellular Ca2+ release patterns. FEBS Lett 2006; 380:
463_8.
25 Burdakov D, Petersen OH, Verkhratsky A. Intraluminal calcium as a primary regulator of endoplasmic reticulum function. Cell Calcium
2005; 38: 303_10.
26 Cornell Bell AH, Finkbeiner SM.
Ca2+ waves in astrocytes. Cell Calcium 1991; 12: 185_204.
27 Cornell Bell AH, Finkbeiner SM, Cooper MS, Smith SJ. Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling.
Science 1990; 247: 470_3.
28 Deitmer JW, Verkhratsky AJ, Lohr C. Calcium signalling in glial cells. Cell Calcium 1998; 24: 405_16.
29 Verkhratsky A, Orkand RK, Kettenmann H. Glial calcium: homeostasis and signaling function. Physiol Rev 1998; 78: 99_141.
30 Bennett MR, Farnell L, Gibson WG. A quantitative model of purinergic junctional transmission of calcium waves in astrocyte networks.
Biophys J 2005; 89: 2235_50.
31 Giaume C, Venance L. Intercellular calcium signaling and gap junctional communication in astrocytes. Glia 1998; 24: 50_64.
32 Anderson CM, Bergher JP, Swanson RA. ATP-induced ATP release from astrocytes. J Neurochem 2004; 88: 246_56.
33 Suadicani SO, Flores CE, Urban-Maldonado M, Beelitz M, Scemes E. Gap junction channels coordinate the propagation of intercellular
Ca2+ signals generated by P2Y receptor activation. Glia 2004; 48: 217_29.
34 Perea G, Araque A. Glial calcium signaling and neuron-glia communication. Cell Calcium 2005; 38: 375_82.
35 Araque A, Parpura V, Sanzgiri RP, Haydon PG. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 1999; 22:
208_15.
36 Volterra A, Haydon P, Magistretti P, editors. Glia in synaptic transmission. Oxford: Oxford University Press; 2002.
37 Verkhratsky A, Kettenmann H. Calcium signalling in glial cells. Trends Neurosci 1996; 19: 346_52.
38 Kirischuk S, Tuschick S, Verkhratsky A, Kettenmann H. Calcium signalling in mouse Bergmann glial cells mediated by alpha1-adrenoreceptors
and H1 histamine receptors. Eur J Neurosci 1996; 8: 1198_208.
39 Kirischuk S, Matiash V, Kulik A, Voitenko N, Kostyuk P,
Verkhratsky A, et al. Activation of P2-purino-,
a1-adreno and H1-histamine receptors triggers cytoplasmic calcium signalling in cerebellar Purkinje neurons. Neuroscience 1996; 73: 643_7.
40 Verkhratsky A, Steinhauser C. Ion channels in glial cells. Brain Res Brain Res Rev 2000; 32: 380_412.
41 Lalo U, Pankratov Y, Kirchhoff F, North RA, Verkhratsky A. NMDA receptors mediate neuron-to-glia signaling in mouse cortical
astrocytes. J Neurosci 2006; 26: 2673_83.
42 Steinhauser C, Gallo V. News on glutamate receptors in glial cells. Trends Neurosci 1996; 19: 339_45.
43 Seifert G, Steinhauser C. Ionotropic glutamate receptors in astrocytes. Prog Brain Res 2001; 132: 287_99.
44 Kirischuk S, Moller T, Voitenko N, Kettenmann H, Verkhratsky A. ATP-induced cytoplasmic calcium mobilization in Bergmann glial
cells. J Neurosci 1995; 15: 7861_71.
45 Dani JW, Chernjavsky A, Smith SJ. Neuronal activity triggers calcium waves in hippocampal astrocyte networks. Neuron 1992; 8:
429_40.
46 Grosche J, Matyash V, Moller T, Verkhratsky A, Reichenbach A, Kettenmann H. Microdomains for neuron-glia interaction: parallel fiber
signaling to Bergmann glial cells. Nat Neurosci 1999; 2: 139_43.
47 Aguado F, Espinosa-Parrilla JF, Carmona MA, Soriano E. Neuronal activity regulates correlated network properties of spontaneous
calcium transients in astrocytes in situ. J Neurosci 2002; 22: 9430_44.
48 Bezzi P, Carmignoto G, Pasti L, Vesce S, Rossi D, Rizzini BL,
et al. Prostaglandins stimulate calcium-dependent glutamate
release in astrocytes. Nature 1998; 391: 281_5.
49 Bezzi P, Gundersen V, Galbete JL, Seifert G, Steinhauser C, Pilati E,
et al. Astrocytes contain a vesicular compartment that is competent
for regulated exocytosis of glutamate. Nat Neurosci 2004; 7: 613_20.
50 Zhang Q, Pangrsic T, Kreft M, Krzan M, Li N, Sul JY. Fusion-related release of glutamate from astrocytes. J Biol Chem 2004; 279:
12724_33.
51 Hua X, Malarkey EB, Sunjara V, Rosenwald SE, Li WH, Parpura V.
Ca2+-dependent glutamate release involves two classes of endoplasmic
reticulum Ca2+ stores in astrocytes. J Neurosci Res 2004; 76: 86_97.
52 Kreft M, Stenovec M, Rupnik M, Grilc S, Krzan M, Potokar M,
et al. Properties of Ca(2+)-dependent exocytosis in cultured astrocytes.
Glia 2004; 46: 437_45.
53 Montana V, Ni Y, Sunjara V, Hua X, Parpura V. Vesicular glutamate transporter-dependent glutamate release from astrocytes. J Neurosci
2004; 24: 2633_42.
54 Hassinger TD, Atkinson PB, Strecker GJ, Whalen LR, Dudek FE, Kossel AH,
et al. Evidence for glutamate-mediated activation of
hippocampal neurons by glial calcium waves. J Neurobiol 1995; 28: 159_70.
55 Sanzgiri RP, Araque A, Haydon PG. Prostaglandin E(2) stimulates glutamate receptor-dependent astrocyte neuromodulation in cultured
hippocampal cells. J Neurobiol 1999; 41: 221_9.
56 Araque A, Sanzgiri RP, Parpura V, Haydon PG. Calcium elevation in astrocytes causes an NMDA receptor-dependent increase in the
frequency of miniature synaptic currents in cultured hippocampal neurons. J Neurosci 1998; 18: 6822_9.
57 Kang N, Xu J, Xu Q, Nedergaard M, Kang J. Astrocytic glutamate release-induced transient depolarization and epileptiform discharges in
hippocampal CA1 pyramidal neurons. J Neurophysiol 2005; 94: 4121_30.
58 Pascual O, Casper KB, Kubera C, Zhang J, Revilla-Sanchez R, Sul JY,
et al. Astrocytic purinergic signaling coordinates synaptic networks.
Science 2005; 310: 113_6.
59 Zonta M, Angulo MC, Gobbo S, Rosengarten B, Hossmann KA, Pozzan T,
et al. Neuron-to-astrocyte signaling is central to the dynamic
control of brain microcirculation. Nat Neurosci 2003; 6: 43_50.
60 Mulligan SJ, MacVicar BA. Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature 2004; 431: 195_9.
61 Nicholls DG, Ward MW. Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Trends
Neurosci 2000; 23: 166_74.
62 Leist M, Nicotera P. Calcium and neuronal death. Rev Physiol Biochem Pharmacol 1998; 132: 79_125.
63 Gillessen T, Budd SL, Lipton SA. Excitatory amino acid neurotoxicity. Adv Exp Med Biol 2002; 513: 3_40.
64 Alberdi E, Sanchez-Gomez MV, Matute C. Calcium and glial cell death. Cell Calcium 2005; 38: 417_25.
65 Salter MG, Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 2005; 438:
1167_71.
66 Karadottir R, Cavelier P, Bergersen LH, Attwell D. NMDA
rece-ptors are expressed in oligodendrocytes and activated in
ischaemia. Nature 2005; 438: 1162_6.
67 Micu I, Jiang Q, Coderre E, Ridsdale A, Zhang L, Woulfe J,
et al. NMDA receptors mediate calcium accumulation in myelin during chemical
ischaemia. Nature 2006; 439: 988_92.
68 Blumenthal I. Periventricular leucomalacia: a review. Eur J Pediatr 2004; 163: 435_42.
69 Caplan LR. Binswanger's disease _ revisited. Neurology 1995; 45: 626_33.
70 Lyons SA, Kettenmann H. Oligodendrocytes and microglia are selectively vulnerable to combined hypoxia and hypoglycemia
injury in vitro. J Cereb Blood Flow Metab 1998; 18: 521_30.
71 Fern R. Ischemia: astrocytes show their sensitive side. Prog Brain Res 2001; 132:
405-11.
72 Fern R. Intracellular calcium and cell death during ischemia in neonatal rat white matter astrocytes
in situ. J Neurosci 1998; 18: 7232_43.
73 Duffy S, MacVicar BA. In vitro ischemia promotes calcium influx and intracellular calcium release in hippocampal astrocytes. J Neurosci
1996; 16: 71_81.
74 Pellerin L, Magistretti PJ. Neuroenergetics: calling upon astrocytes to satisfy hungry neurons. Neuroscientist 2004; 10: 53_62.
75 Desagher S, Glowinski J, Premont J. Astrocytes protect neurons from hydrogen peroxide toxicity. J Neurosci 1996; 16: 2553_62.
76 Kofuji P, Newman EA. Potassium buffering in the central nervous system. Neuroscience 2004; 129: 1045_56.
77 Budd SL, Lipton SA. Calcium tsunamis: do astrocytes transmit cell death messages via gap junctions during ischemia? Nat Neurosci 1998;
1: 431_2.
78 Lin JH, Weigel H, Cotrina ML, Liu S, Bueno E, Hansen
AJ, et al. Gap-junction-mediated propagation and amplification of cell injury. Nat
Neurosci 1998; 1: 494_500.
79 Cotrina ML, Kang J, Lin JH, Bueno E, Hansen TW, He L,
et al. Astrocytic gap junctions remain open during ischemic conditions. J
Neurosci 1998; 18: 2520_37.
80 Leao AAP. Spreading depression of activity in the cerebral cortex. J Neurophysiol 1944; 7: 359_90.
81 Pietrobon D. Migraine: new molecular mechanisms. Neuroscientist 2005; 11: 373_86.
82 Walz W. Role of astrocytes in the spreading depression signal between ischemic core and penumbra. Neurosci Biobehav Rev 1997; 21:
135_42.
83 Nedergaard M, Hansen AJ. Characterization of cortical depolarizations evoked in focal cerebral ischemia. J Cereb Blood Flow Metab 1993;
13: 568_74.
84 Gehrmann J, Mies G, Bonnekoh P, Banati R, Iijima T, Kreutzberg GW,
et al. Microglial reaction in the rat cerebral cortex induced by
cortical spreading depression. Brain Pathol 1993; 3: 11_7.
85 Kraig RP, Dong LM, Thisted R, Jaeger CB. Spreading depression increases immunohistochemical staining of glial fibrillary acidic protein.
J Neurosci 1991; 11: 2187_98.
86 Konnerth A, Heinemann U, Yaari Y. Nonsynaptic epileptogenesis in the mammalian hippocampus
in vitro. I. Development of seizurelike activity in low extracellular calcium. J Neurophysiol 1986; 56: 409_23.
87 Yaari Y, Konnerth A, Heinemann U. Nonsynaptic epileptogenesis in the mammalian hippocampus
in vitro. II. Role of extracellular potassium. J Neurophysiol 1986; 56: 424_38.
88 Kang N, Xu J, Xu Q, Nedergaard M, Kang J. Astrocytic glutamate release-induced transient depolarization and epileptiform discharges in
hippocampal CA1 pyramidal neurons. J Neurophysiol 2005; 94: 4121_30.
89 Fellin T, Haydon PG. Do astrocytes contribute to excitation underlying seizures? Trends Mol Med 2005; 11: 530_3.
90 Tian GF, Azmi H, Takano T, Xu Q, Peng W, Lin J,
et al. An astrocytic basis of epilepsy. Nat Med 2005; 11: 973_81.
91 Kim JH. Pathology of epilepsy. Exp Mol Pathol 2001; 70: 345_67.
92 Blumcke I, Thom M, Wiestler OD. Ammon's horn sclerosis: a maldevelopmental disorder associated with temporal lobe epilepsy. Brain
Pathol 2002; 12: 199_211.
93 Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiat Psych-Gericht Med 1907; 64: 146_8.
94 Nagele RG, Wegiel J, Venkataraman V, Imaki H, Wang KC. Contribution of glial cells to the development of amyloid plaques in
Alzheimer's disease. Neurobiol Aging 2004; 25: 663_74.
95 Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, Yan F,
et al. Adult mouse astrocytes degrade amyloid-beta
in vitro and in situ. Nat Med 2003; 9: 453_7.
96 Abramov AY, Canevari L, Duchen MR. Calcium signals induced by amyloid beta peptide and their consequences in neurons and astrocytes
in culture. Biochim Biophys Acta 2004; 1742: 81_7.
97 Abramov AY, Canevari L, Duchen MR. Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of
amyloid neurotoxicity. J Neurosci 2003; 23: 5088_95.
|